A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma.
Saved in:
| Title: | A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma. |
|---|---|
| Authors: | Hainsworth, John D.1,2 (AUTHOR) jhainsworth@tnonc.com, Infante, Jeffrey R.1,2 (AUTHOR), Spigel, David R.1,2,3 (AUTHOR), Arrowsmith, Edward R.1,3,4 (AUTHOR), Boccia, Ralph V.1,4 (AUTHOR), Burris, Howard A.1,2 (AUTHOR) |
| Source: | Cancer Investigation. Aug2011, Vol. 29 Issue 7, p451-455. 5p. 2 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
